PHARMACOKINETICS OF MIBAVADEMAB (MIBA) IN HEALTHY PARTICIPANTS: RESULTS FROM A RANDOMIZED, PHASE 1, TWO-PART, FIRST-IN-HUMAN STUDY

被引：0
|
作者：
Mendell, J. [1 ]
Gewitz, A. [1 ]
Wang, Y. [1 ]
Harnisch, L. [1 ]
Olenchock, B. [1 ]
Pan, H. [1 ]
Podgrabinska, S. [1 ]
Zheng, W. [1 ]
Zhao, A. [1 ]
Vanhoutte, F. [2 ]
Davis, J. [1 ]
机构：
[1] Regeneron Pharmaceut, Tarrytown, NY USA
[2] SGS Clin Pharmacol Unit, Antwerp, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-074
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first-in-human phase I study
    Gewitz, Andrew
    Mendell, Jeanne
    Wang, Yuhuan
    Harris, Charles
    Olenchock, Benjamin A.
    Podgrabinska, Simona
    Zheng, Wenjun
    Zhao, An
    Pan, Hao
    Vanhoutte, Frederic
    Davis, John D.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [2] Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study
    Xie, Panpan
    He, Xuemei
    Gao, Xin
    Shuai, Mengmeng
    Schmider, Wolfgang
    Jiang, Alex
    Yang, Na
    Shi, Aixin
    DIABETES THERAPY, 2023, 14 (08) : 1387 - 1397
  • [3] Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study
    Panpan Xie
    Xuemei He
    Xin Gao
    Mengmeng Shuai
    Wolfgang Schmider
    Alex Jiang
    Na Yang
    Aixin Shi
    Diabetes Therapy, 2023, 14 : 1387 - 1397
  • [4] Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study
    Vanhoutte, Frederic
    Liang, Su
    Ruddy, Marcella
    Zhao, An
    Drewery, Tiera
    Wang, Yuhuan
    DelGizzi, Richard
    Forleo-Neto, Eduardo
    Rajadhyaksha, Manoj
    Herman, Gary
    Davis, John D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (11): : 1424 - 1431
  • [5] A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants
    Lim, Chay Ngee
    Kantaridis, Constantino
    Huyghe, Isabelle
    Gorman, Donal
    Berasi, Stephen
    Sonnenberg, Gabriele E.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (04):
  • [6] First-in-Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC-0974, an Anti-Hemojuvelin Antibody, in Healthy Participants
    Novikov, Natasha
    Buch, Akshay
    Yang, Hua
    Andruk, Michelle
    Liu, Guowen
    Wu, Min
    Howell, Haley
    Macdonald, Brian
    Savage, Will
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (08): : 953 - 962
  • [7] Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
    McCarthy, James S.
    Lotharius, Julie
    Ruckle, Thomas
    Chalon, Stephan
    Phillips, Margaret A.
    Elliott, Suzanne
    Sekuloski, Silvana
    Griffin, Paul
    Ng, Caroline L.
    Fidock, David A.
    Marquart, Louise
    Williams, Noelle S.
    Gobeau, Nathalie
    Bebrevska, Lidiya
    Rosario, Maria
    Marsh, Kennan
    Mohrle, Jorg J.
    LANCET INFECTIOUS DISEASES, 2017, 17 (06): : 626 - 635
  • [8] First-in-human results from a phase 1 single- and multiple-ascending dose study in healthy participants assessing the safety, pharmacokinetics, and pharmacodynamics of the interleukin-17A inhibitor JNJ-81241459
    Ling, I.
    Leung, M.
    Piantone, A.
    Sinha, V.
    Song, D.
    Scott, B.
    Pryor, M.
    Verbruggen, K.
    La, D.
    Tikhonov, I.
    Ceulemans, K.
    Nischal, S.
    Polak, M.
    Eidam, P.
    Goldberg, S.
    Rao, R.
    Yang, Y-W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S375 - S375
  • [9] Safety and Pharmacokinetics of Single-Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
    Xu, Junyu
    Xie, Ran
    Ji, Yongjia
    Qian, Chenxi
    Zhang, Xin
    Todd, Kris
    Wang, Feng
    Cui, Yimin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (10): : 1143 - 1150
  • [10] A phase I/II, two-part, multicenter, first-in-human study of DS-7300a in patients with advanced solid malignant tumors.
    Bendell, Johanna C.
    Doi, Toshihiko
    Patel, Manish R.
    Piha-Paul, Sarina Anne
    Sen, Shiraj
    Shimizu, Toshio
    Cheng, Ben
    Mekan, Sabeen F.
    Myobatake, Yusuke
    Okuda, Yasuyuki
    Serbest, Gul
    Johnson, Melissa Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345